| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.23 | 7e-07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.067 | 0.2 |